<DOC>
	<DOCNO>NCT01060488</DOCNO>
	<brief_summary>The aim study determine specificity sensitivity combine growth hormone release hormone ( GHRH ) + Arginine test healthy volunteer , subject highly probable adult growth hormone deficiency ( AGHD ) subject probably free AGHD .</brief_summary>
	<brief_title>Comparative Validation Growth Hormone Releasing Hormone Arginine Test Diagnosis Adult Growth Hormone Deficiency</brief_title>
	<detailed_description>The randomisation carry first test perform . In order inform subject 's randomisation group , investigator phone access number give him/her . The subject 's allocation give randomisation arm determine basis centralise randomisation ( answer service ) , balance per group subject minimisation 2 criterion : age BMI . This centralised randomisation use Interactive Voice Response System ( IVRS ) balance follow 3 category subject : - Category A = healthy volunteer , - Category B = subject strong probability deficit GH , - Category C = subject low probability deficit GH . In 3 category , subject underwent 3 test whose sequence determine follow randomisation group : - Group 1 : GHRH+Arg , GHRH+Arg , ITT - Group 2 : ITT , ITT , GHRH+Arg .</detailed_description>
	<mesh_term>Endocrine System Diseases</mesh_term>
	<mesh_term>Dwarfism , Pituitary</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Growth Hormone-Releasing Hormone</mesh_term>
	<criteria>Subjects age 18 year 60 year , Female male , Subjects treat GH stop treatment 15 day ago , Effective contraception woman childbearing age : hormonal contraception use female condom spermicide use diaphragm spermicide Intra Uterine Device ( IUD ) , Signed informed consent , Subjects possess social security cover . Subjects least one follow criterion consider subject high probability present GH deficit : Subjects tumour hypothalamohypophyseal region ( hypophyseal adenoma , craniopharyngioma , meningioma , etc . ) presence hypophyseal insufficiency GH must test preoperatively postoperatively , Subjects present secondary antehypophyseal insufficiency inflammatory , infectious , posttraumatic pathology hypophyseal necrosis , whose hypophyseal functional condition already document revaluation GH secretion desire , Subjects undergone , adult , irradiation hypothalamohypophyseal region , suprasellar irradiation , clinical context GH deficit , Subjects know organic antehypophyseal insufficiency begin childhood least 1 associated deficit exclude prolactin . Subjects least one follow criterion consider subject low probability present GH deficit : Subjects know idiopathic isolate GH deficit start childhood new growth hormone secretion test desire , Subjects nonoperated microadenoma ( &lt; 1 cm diameter ) , Subjects fortuitously discover intrasellar image ( e.g . Rathke 's pocket cyst ) . The third category subject eligible make healthy volunteer . Subjects present coronary history whose electrocardiographic sign evoke ischemic pathology , Subjects present history cerebrovascular insufficiency , Subjects present history epilepsy , Subjects evolutive acromegalia evolutive Cushing 's syndrome , Subjects present know intolerance arginine , GHRH insulin , Hyperkalemic subject , Diabetic subject ( Type 1 Type 2 ) , Very obese subject ( BMI &gt; 40 ) , Subjects present severe , hepatic , renal , tumoral evolutive affection metabolic respiratory acidosis , Subjects know immunodepression , Subjects psychiatric disorder , Subjects present Parkinson 's disease Parkinsonian syndromes treated LevodopaÂ® , Subjects treat drug directly affect hypophyseal secretion somatotrophin ( e.g . clonidine , levodopa ) provoke release somatostatin , antimuscarinic agent ( atropine ) , Subjects untreated hypothyroidism subject treat antithyroid synthesis drug , Participation another biomedical research programme le 3 month previously , Known evolutive pregnancy breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>GH secretion test</keyword>
	<keyword>adverse effect</keyword>
	<keyword>adult growth hormone deficiency</keyword>
	<keyword>growth-hormone release hormone arginine test</keyword>
	<keyword>insulin tolerance test</keyword>
	<keyword>GHRH + Arginine test</keyword>
</DOC>